Back to today’s briefing

Story perspectives

Experimental Drug Ulefnersen Offers Hope for ALS Patients

5/24/2025

50 7

Summary

Story summary

A groundbreaking experimental drug, ulefnersen, is making waves in the fight against a rare and aggressive form of ALS tied to FUS gene mutations. In a small study of 12 patients, two individuals achieved remarkable recoveries, even regaining their ability to walk. With a global clinical trial underway, hope is on the horizon for many.

1 of 1

Story summary

A groundbreaking experimental drug, ulefnersen, is making waves in the fight against a rare and aggressive form of ALS tied to FUS gene mutations. In a small study of 12 patients, two individuals achieved remarkable recoveries, even regaining their ability to walk. With a global clinical trial underway, hope is on the horizon for many.